HOME >> BIOLOGY >> NEWS
Too much grape juice could cause iron deficiency

The same antioxidant compounds in dark grape juice that are noted for their health benefits in fighting heart disease may have a downside, according to new research in the Journal of Agricultural and Food Chemistry. In cell studies, scientists with the U.S. Department of Agriculture and Cornell University found that polyphenols in purple (also called red) grape juice can inhibit the uptake of iron, which could increase the risk of iron-deficiency anemia.

The findings still need to be confirmed in human studies, cautions the study's lead author, Raymond P. Glahn, Ph.D., a physiologist/nutritionist with the USDA's Plant, Soil and Nutrition Laboratory, located on the Cornell campus in Ithaca, N.Y. The study, which appears in the Nov. 6 issue of the journal, is the first comparative analysis among juices for iron uptake ability. The journal is published by the American Chemical Society, the world's largest scientific society.

While reducing iron can be beneficial for adults with certain medical conditions that involve excess iron, the same isn't necessarily true for young children. Iron-deficiency anemia can lead to mental, physical and behavioral impairment, particularly in infants and toddlers, say the researchers.

While iron-deficiency anemia is a major problem among children worldwide, youngsters in the United States are largely spared this problem by iron fortification of cereals, formulas and other foods, according to nutrition experts. Many children in this country, however, still do not get enough iron, notes Glahn.

Nonetheless, Glahn does not advocate removing dark grape juice from children's diets. Instead, he suggests limiting the amount.

"Since we don't know how much grape juice you have to drink to have an effect, I recommend alternating between dark and light juices. Don't just drink dark juices all the time," Glahn says.

"We're not saying, 'Don't drink grape juice,'" Glahn emphasizes. "We're say
'"/>

Contact: Beverly Hassell
b_hassell@acs.org
202-872-4065
American Chemical Society
12-Dec-2002


Page: 1 2

Related biology news :

1. Researchers target deficit irrigation for wine grapes
2. Drinking concord grape juice may reduce blood pressure in hypertensive men
3. Compound identified in grapes may fight cancer and diabetes
4. Technology patented to create Pierces disease-resistant grapevines
5. Like grapefruit, sour oranges boost drug effectiveness, scientists find, and also why
6. New process improves potency, uses of grape seed extracts
7. DNA fingerprinting reveals surprise in wine-grape family tree
8. Additive that makes juices tart quadruples yield of essential hemophilia treatment
9. Cola soft drinks satisfy hunger as well as orange juice or 1% milk
10. UC Davis study finds heart benefits from apples & juice
11. New treatment makes fruit juices safer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Too much grape juice could cause iron deficiency

(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) ... among grasses , Within the genome of each ... undergo little change in position and sequence over millions ... Some of these evolutionarily stable sequences, so-called conserved noncoding ... other genes or the condensation of chromosomes, but the ...
(Date:5/23/2013)... year, carrying more than 284 million tons of cargo, transit ... in toll fees for the Panama Canal Authority. Each time ... water are used from Gatun Lake, which is also a ... the isthmus. , However, the advent of very large ... ships at sea, has demanded change. The Panama Canal is ...
(Date:5/23/2013)... The tight wrapping of genomic DNA around nucleosomes ... gene expression. A team of Ludwig-Maximilians-Universitaet (LMU) in ... DNA to be locally displaced from nucleosomes for ... is stored in the cell nucleus, wrapped around ... pairs of four different histone proteins and accommodating ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3Biochemistry: Unspooling DNA from nucleosomal disks 2
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a ... research and development, sales and marketing of premium ... today that it is awarding exclusive Vestiage territories ... Reluma Skin Illuminating Facial Care. Qualified applicants can ... an email to info(at)vestiageinc(dot)com and putting RELUMA in ...
(Date:5/23/2013)... 2013  BioScrip, Inc. (NASDAQ: BIOS ) ... Jefferies 2013 Global Healthcare Conference to be held June ... Richard Smith , President and ... , Chief Financial Officer, will present on Monday, June ... About BioScrip BioScrip, Inc. provides comprehensive ...
(Date:5/23/2013)... BROWNSBURG, Ind. , May 23, 2013  Rahal ... leader in human cord blood stem cell banking and ... sponsor of the No. 16 Acorn Stairlifts Indy car ... is for the remainder of the IZOD IndyCar 2013 ... Racing (RLL) will work to support awareness of umbilical ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
Cached News: